论文信息 - JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease. - 字舞流文

JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.

K. Rhodes | A. Megens | X. Langlois | B. Shook | J. Atack | W. Drinkenburg | S. Rassnick | P. Jackson | A. Ahnaou | P. te Riele | B. Hrupka | H. Hendrickx | N. Aerts | P. De Haes | K. Hens | A. Wellens | J. Vermeire